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Abstract The yeast ERV1 gene encodes a small polypeptide of
189 amino acids that is essential for mitochondrial function and
for the viability of the cell. In this study we report the enzymatic
activity of this protein as a flavin-linked sulfhydryl oxidase
catalyzing the formation of disulfide bridges. Deletion of the
amino-terminal part of Erv1p shows that the enzyme activity is
located in the 15 kDa carboxy-terminal domain of the protein.
This fragment of Erv1p still binds FAD and catalyzes the
formation of disulfide bonds but is no longer able to form dimers
like the complete protein. The carboxy-terminal fragment
contains a conserved CXXC motif that is present in all
homologous proteins from yeast to human. Thus Erv1p
represents the first FAD-linked sulfhydryl oxidase from yeast
and the first of these enzymes that is involved in mitochondrial
biogenesis. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The yeast ERV1 gene is the best characterized representa-
tive of a gene family found in a large number of lower and
higher eukaryotes [1^3] and in the genomes of some double-
stranded DNA viruses [4^6]. The gene encodes a small protein
of 22 kDa that has a complex in£uence on di¡erent aspects of
mitochondrial biogenesis [2,3,7] and is essential for the surviv-
al of the yeast cell [1]. Recently, it was shown that the protein
is essential for a normal mitochondrial morphology and for
stable maintenance of these organelles in the cell [7,8]. Mam-
malian homologues of Erv1p exist in man, mouse and rat.
The homologous mammalian ALR (augmenter of liver regen-
eration) proteins of about 25 kDa have been characterized as
important hepatic growth factors [9^11]. One characteristic
feature of these proteins is the highly divergent amino-termini
that are responsible for di¡erent subcellular distributions [5^
8]. In contrast, the carboxy-terminal domains are highly con-
served and can be functionally interchanged between yeast
and human cells [8,12]. In accordance with its essential func-
tion in yeast the ERV1 protein is found in the cytosol and
inside mitochondria [7,8]. No enzymatic function has been
assigned to this class of proteins yet.
One indication for a possible enzymatic function is the ¢nd-
ing that a growth factor of human ¢broblast cells, the Q6
protein, contains a domain with faint but signi¢cant homol-
ogies to the conserved domain of Erv1p and Alrp [6]. With
582 amino acids the Q6 protein is much larger than Erv1p and
recently it was shown that during metazoan evolution Q6 was
created by the fusion of di¡erent protein domains [6]. One of
those domains of Q6 contains a CXXC motif that is the re-
dox-active site of a £avin-linked sulfhydryl oxidase [13]. A
similar motif is found in the conserved domains of yeast
Erv1p and human Alrp [6,8,11].
In this communication we report that puri¢ed yeast Erv1p
has the enzymatic activity of a £avin-linked sulfhydryl oxidase
[13^15]. The carboxy-terminal domain with the conserved
CXXC motif binds FAD and contains the enzymatic activity.
Erv1p is only distantly related to human Q6 as the two pro-
teins have adapted to di¡erent functions during evolution.
The most important di¡erences between Erv1p and Q6 con-
cern the rate of enzyme activity, subcellular localization and
the molecular weight. The assignment of a sulfhydryl oxidase
activity to Erv1p is important to de¢ne its molecular targets
inside yeast cells and to elucidate the role of the homologous
mammalian Alrp in hepatic cell growth.
2. Materials and methods
2.1. Polymerase chain reaction (PCR experiments)
The complete yeast ERV1 gene and a shorter fragment encoding the
carboxy-terminus were ampli¢ed by standard protocols [16] using the
Taq polymerase kit (Roche Mannheim), the yeast cDNA clone for
ERV1 [3] and the following primers: primer 1: 5P-AATACAAAGC-
CATATGAAAGCAATAGATAAAATG-3P (¢rst ATG of ERV1/
NdeI); primer 2: 5P-CTTCAGAGCATATGCCTGGCTCAAGAAC-
ATAC-3P (second ATG of ERV1/NdeI); primer 3: 5P-GATTGCTC-
GAGTTCGTCCCAGCCGTCCTTCCA-3P (stop codon of ERV1/
XhoI). The restriction sites NdeI (primers 1 and 2) and XhoI (primer
3) are underlined. These restriction sites have been introduced into the
primers for cloning the PCR fragments into the hexahistidyl tag vec-
tor pET-24a(+) (Novagen).
2.2. Puri¢cation of the yeast Erv1p-6His proteins from Escherichia coli
The two PCR constructs encoding the complete protein and a car-
boxy-terminal fragment of Erv1p were expressed in E. coli strain
BL21 (Clontech). The presence of the hexahistidyl tag at the car-
boxy-terminus of the proteins allowed rapid puri¢cation with nickel
agarose according to the standard protocols for the isolation under
native conditions in NaCl^phosphate bu¡er (50 mM NaCl, 50 mM
KH2PO4, 10 mM imidazole, pH 7.5) (Qiagen). Proteins were bound
to nickel agarose and eluted with 50 mM NaCl, 50 mM KH2PO4, 200
mM imidazole, pH 7.5. Puri¢cation to homogeneity was veri¢ed by
SDS^polyacrylamide gels and by antibody tests. In a ¢nal step the
proteins were dialyzed against 50 mM Tris^HCl pH 8.0.
2.3. Spectroscopy of yeast Erv1p-6His
The dialyzed proteins were directly used for spectroscopy. The visi-
ble spectra of these protein solutions were recorded with an S-10
diode array photometer (Zeiss). Under identical conditions a reference
of 15 WM puri¢ed FAD (Sigma) was measured.
To test the reversible reduction of protein-bound FAD a 600 Wl
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sample of 25 WM Erv1p in elution bu¡er (200 mM imidazole, 50 mM
phosphate pH 7.5, 200 mM NaCl) was completely reduced with a few
grains of Na-dithionite. The visible spectra were recorded in a JpM
diode array photometer for 30 min. The oxidation of dithionite was
followed at 315 nm and FAD was recorded at 460 nm.
2.4. Preparation of reduced lysozyme as a substrate for Erv1p
The reduction of lysozyme was done as described elsewhere [15] by
dissolving 20 mg lysozyme (Serva) in 1 ml of degassed 100 mM Tris
bu¡er containing 6 M guanidine hydrochloride and 0.3 mM EDTA,
followed by the addition of dithiothreitol (DTT) to a ¢nal concentra-
tion of 6 mM. The solution was incubated at pH 8.0 overnight at
37‡C and then adjusted to pH 3.5 with glacial acetic acid. DTT was
removed by a Sephadex G25 column equilibrated with deoxygenated
8 M urea containing 0.1% acetic acid (v/v) and 0.3 mM EDTA.
2.5. Enzyme assay for sulfhydryl oxidase
Yeast ERV1 proteins of the long and short form corresponding to
600 pmol bound FAD were diluted in 1.2 ml measurement bu¡er (2 M
urea in 100 mM potassium phosphate bu¡er pH 7.5 containing 1 mM
EDTA) together with reduced lysozyme that corresponds to 55 nmol
reduced thiol groups. The initial content of thiol groups was deter-
mined from a sample withdrawn before the addition of the protein.
Aliquots of 200 Wl were withdrawn at di¡erent time intervals and
determined for their thiol content. For this purpose samples were
diluted with 790 Wl of measurement bu¡er and then 10 Wl DTNB
(Ellman’s reagent [17]) was added to a ¢nal concentration of 10 WM.
After 2 min the extinction at 412 nm was measured and the thiol
content was calculated using an extinction coe⁄cient of 13.6 mM31
cm31.
2.6. Isolation of native Erv1p-GFP from yeast cells
In previous experiments [7,8] Erv1p was expressed as a fusion pro-
tein with GFP from an episomal plasmid transformed into yeast. For
the preparation of native protein this yeast strain was grown to early
logarithmic phase in glucose minimal medium. From 5 ml culture
medium the cells were collected in an Eppendorf tube and disrupted
with glass beads in NaCl^phosphate bu¡er (200 mM NaCl, 50 mM
KH2PO4, pH 7.5) using a Brown homogenizer. After high speed cen-
trifugation the clear supernatant was used for the experiments. Ali-
quots with 50 Wg of total protein were applied to SDS^polyacrylamide
gels.
2.7. Standard techniques
E. coli strains DH5-K [18] and BL21 (Clontech) were used for
cloning experiments and ampli¢cation of plasmid DNA. Plasmid
DNA was isolated from E. coli by alkaline lysis [19]. Puri¢cation,
restriction enzyme digestion, ligation and analysis of yeast DNA or
PCR products on agarose gels were performed as described [20]. Nu-
cleotide sequences of the DNA constructs were controlled by the bio-
chemical method that uses T7 polymerase, [K-35S]dATP and the ap-
propriate primers [21].
3. Results
3.1. Yeast Erv1p contains a FAD moiety
Sulfhydryl oxidases from chicken egg white and the human
Q6 growth regulator [13] depend on a FAD molecule for their
enzyme activity [14,15]. Therefore it was tested whether puri-
¢ed Erv1p contains FAD. For this purpose full-length Erv1p
and a shorter fragment (Fig. 1) were expressed in E. coli with
a hexahistidyl tag attached to the carboxy-terminus and puri-
¢ed to homogeneity. Fig. 2 shows the nearly identical visible
spectra of the short and the long form of Erv1p. Those spec-
tra are typical for an FAD moiety and exhibit the distinct
di¡erences from free FAD [15]. The absorbance maximum
of free FAD at 450 nm is shifted by about 10 nm in the
protein. The shoulder at 480 is also shifted and appears
more pronounced for protein-bound FAD. The FAD content
of the proteins was calculated from the OD460 values using an
extinction coe⁄cient of 10 mM31 cm31. After determination
of the protein concentration it was calculated that about 0.8
FAD molecules per monomer unit of protein are found. This
value suggests the presence of one FAD molecule per mono-
mer unit. Treatment of the protein with 6 M urea completely
removed the FAD molecule, demonstrating that it is ¢rmly
attached but not covalently linked to the protein. Finally, it
was tested whether the bound FAD of Erv1p can be reversibly
reduced with dithionite and oxygen. Addition of dithionite to
a sample of Erv1p completely reduced the FAD component
(for details see Section 2). After excess of dithionite was oxi-
dized by air, the FAD component was completely reoxidized
in less than 1 min. Compared to free FAD the redox reactions
of Erv1p with dithionite and oxygen were about 10 times
slower and not linear. Both the alterations of the spectra
and the slower kinetics of the redox reactions are clear indi-
cations that the FAD is bound to the protein [14,15].
3.2. The yeast Erv1p protein has a sulfhydryl oxidase activity
The identi¢cation of bound FAD and the presence of a
CXXC motif (see Fig. 1) in yeast Erv1p with some similarities
to the redox-active site of sulfhydryl oxidases [13] were further
indications for a comparable enzyme activity of the yeast
protein. To verify this hypothesis full-length Erv1p and the
shorter fragment (Fig. 1) were investigated for the ability to
introduce disul¢de bonds into protein. Completely reduced
lysozyme was used as a substrate after dilution in mildly de-
naturing bu¡er to make all thiol groups accessible for the
enzyme. The reactions were started by adding the puri¢ed
yeast Erv1p proteins to the substrate mixture. At di¡erent
time points aliquots were withdrawn and assayed for their
Fig. 1. Domain structure of yeast Erv1p. The protein contains 189
amino acids. The amino-terminal part with the ¢rst 72 amino acids
(gray bar) has no sequence homologies with any other protein. The
carboxy-terminal domain (white bar) from amino acid 73 to 189 has
about 40% amino acid homology with mammalian Alrp [12] and
contains a conserved CXXC motif. Sequence alignments of this re-
gion are shown for yeast (sc) Erv1p, human (h), mouse (m) and rat
(r) Alrp. Identical amino acids found at the same position in all
four proteins are marked by asterisks. Amino acids that are di¡er-
ent between the human, mouse and rat protein are written in small
letters. Numbers at the end of the sequences give the position of the
amino acids in the proteins. The conserved amino acids associated
with the CXXC motif are underlined and written in bold letters.
The boxed phenylalanine residue is present in all proteins and is es-
sential for a functional yeast Erv1p [2,3]. The domain of the human
Q6 protein (hQ6) that contains the cysteine pair of the redox-active
site is included in this ¢gure. Important amino acids that de¢ne the
consensus motif for Q6 proteins are written in bold letters and
underlined [13].
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thiol content [17]. For the full-length yeast Erv1p of 22 kDa
and the carboxy-terminal fragment of 15 kDa a linear oxida-
tion of the substrate was observed (see Fig. 3). The turnover
numbers for the enzymes were 8.6 min31 for the full-length
protein and 7.8 min31 for the carboxy-terminal fragment.
3.3. Erv1p isolated from yeast forms a dimer under
non-reducing conditions
In previous experiments a Erv1p-GFP fusion protein was
used to investigate the subcellular localization of the protein
[7,8]. Total protein extracts from the yeast cells expressing this
fusion protein were prepared under native conditions without
reducing agents in the bu¡er. Aliquots of these total protein
extracts containing Erv1p-GFP were separated in SDS^poly-
acrylamide gels with or without reducing agent in the loading
bu¡er of the sample. Fig. 4a shows the protein pattern after
Western blot and immunodetection with an antibody speci¢c
for GFP. For the sample without any reducing agent a major
protein band of 100 kDa is detected that corresponds to a
homodimer and in addition a minor band of 50 kDa that
represents the monomer. Addition of reducing agent to the
sample results in the detection of a single band of 50 kDa for
the monomer.
3.4. The amino-terminus of Erv1p is essential for dimer
formation
Full-length Erv1p and the carboxy-terminal fragment were
puri¢ed from E. coli under native extraction conditions and
both proteins were tested for the ability to form dimers. The
results are included in Fig. 4b,c. The long form of Erv1p-6His
isolated from E. coli gave a comparable pattern of protein
bands to Erv1p-GFP from yeast cells. Under non-reducing
conditions the dimer of 44 kDa and the monomer of 22
kDa are both present. In contrast to this ¢nding the 15 kDa
carboxy-terminal fragment of Erv1p-6His shows no detectable
formation of any dimer complex in the sample without reduc-
Fig. 2. Spectroscopy of the puri¢ed 22 kDa and 15 kDa fragments
of yeast Erv1p. The absorbance in the range from 350 nm to 550
nm was measured. Solid lines represent the spectra for the long (22
kDa) and short (15 kDa) forms of yeast Erv1p and the thin line a
reference sample with 15 WM pure FAD. The Erv1p spectra are
characteristic for an FAD moiety, but show distinct di¡erences
from free FAD. The absorbance maximum in the range of 450 nm
is shifted about 10 nm in the protein sample. Dashed lines with ar-
rows mark the position of the maximum for protein-bound and free
FAD. The shoulder in the spectra at 480 nm is also shifted and ap-
pears more pronounced in protein-bound FAD [14,15] (for details
see Section 2).
Fig. 3. Sulfhydryl oxidase assay with full-length Erv1p and a 15
kDa carboxy-terminal fragment. Hexahistidyl-tagged proteins were
expressed in E. coli and puri¢ed to homogeneity by nickel agarose.
Reduced lysozyme corresponding to 55 nm thiol groups was incu-
bated with Erv1p. The concentration of the short and long forms of
Erv1p was adjusted to 50 pmol bound FAD for each measured
sample. Oxidation of thiol groups was measured spectroscopically at
412 nm after addition of 10 WM DTNB by determining the decrease
of extinction at the listed time points. The values for the 22 kDa
protein are marked by F and for the 15 kDa fragment by b. Identi-
cal samples without protein (U) or with equal amounts of pure
FAD alone (7) were incubated under the same conditions (for de-
tails see Section 2).
Fig. 4. Investigation of dimer formation for Erv1p. a: Erv1p is iso-
lated as a dimer from yeast cells. Aliquots of 50 Wg total protein ex-
tracts from yeast cells expressing the fusion protein Erv1p-GFP
were separated in a 4^12% SDS^polyacrylamide gel with (+) or
without (3) 10 mM DTT in the sample bu¡er. Arrows indicate the
position of bands with a molecular weight of about 100 kDa
(dimer) or 50 kDa (monomer). Protein bands were visualized by a
monoclonal antibody against GFP and chemiluminescence. The
same analysis was done with the long form (b) and the short form
of Erv1p-6His (c) isolated from E. coli. Aliquots of 50 ng highly pu-
ri¢ed Erv1p-6His (22 kDa or 15 kDa) were used for this purpose.
Arrows point to the position of bands with a molecular weight of
about 44 kDa (dimer) or 22 kDa (monomer) and 15 kDa (mono-
mer). Only the long form of Erv1p can form dimers under these
conditions. Protein bands were visualized by antibodies against the
hexahistidyl tag using chemiluminescence.
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ing agent, indicating that the intact amino-terminus is essen-
tial for the formation of dimers.
4. Discussion
In this communication Erv1p is identi¢ed as a FAD-linked
sulfhydryl oxidase by its ability to oxidize thiol groups in a
protein substrate, the presence of a FAD moiety in the car-
boxy-terminal domain and the formation of dimers in vivo
and in vitro. The bound FAD is reversibly reducible with
dithionite and oxygen indicating a functional involvement in
the enzymatic activity [15]. The full-length ERV1 protein and
the truncated 15 kDa fragment both contain FAD and exhibit
signi¢cant sulfhydryl oxidase activities. Comparable enzyme
activities of both Erv1p forms indicate that the amino-termi-
nus is not required for the catalytic reaction. The ¢nding that
the 15 kDa fragment of Erv1p exists as a monomer demon-
strates that the amino-terminus is essential for dimer forma-
tion but that dimerization is not essential for the function in
disul¢de formation. Dimers of Erv1p may be essential for the
function in yeast as previous experiments demonstrated that
the amino-terminus is indispensable for an active Erv1p in
vivo [3,8].
The location of the sulfhydryl oxidase activity in the 15
kDa carboxy-terminal fragment of the protein is in accor-
dance with the ¢nding that this domain contains a conserved
CXXC motif (Fig. 1). Alignment of the consensus sequences
for Erv1p/Alrp, human Q6 and the homologous chicken egg
white sulfhydryl oxidase [13] shows the similarities of these
CXXC motifs, but also exhibits speci¢c di¡erences that iden-
tify Erv1p/Alrp as a sub-class of their own. The functional
importance of this domain is further stressed by a mutation in
ERV1 that changes a conserved phenylalanine residue next to
this CXXC motif (see Fig. 1) thereby causing a severe defect
in yeast [1,2]. Amino acids of functional importance like ar-
omatic and charged amino acids are conserved in the neigh-
borhood of the two vicinal cysteine residues in all proteins,
but the yeast Erv1p and the mammalian Alrp CXXC motifs
are still more closely related to each other than human Alrp
and the human Q6 protein domain.
In spite of similar enzyme activities Erv1p and human Q6
are only distantly related indicating adaptations to di¡erent
cellular functions during evolution. The most signi¢cant dif-
ferences concern the subcellular localization, enzyme activity
and molecular weight. The chicken enzyme and the human Q6
protein of about 600 amino acids are both secreted from cells
and are discussed to have a function in the formation of the
extracellular matrix whereas the 22 kDa yeast Erv1p is found
in the cytosol and inside mitochondria [7,8]. The enzyme turn-
over number of Erv1p is about 10% of that of the native
chicken enzyme [14,15] when one uses lysozyme as an in vitro
substrate. The slower enzyme turnover number of yeast Erv1p
might in part be explained by the heterologous expression in
E. coli and incomplete natural folding of the protein. How-
ever, the most likely explanation is a di¡erent substrate spe-
ci¢city for yeast and human enzymes as lysozyme cannot be
the preferred natural substrate for Erv1p. The speci¢c func-
tion of Erv1p in mitochondrial biogenesis indicates that this
enzyme has been adapted to speci¢c targets in yeast and does
not represent a general sulfhydryl oxidase for many di¡erent
cellular proteins. In accordance with this hypothesis our latest
experiments show that glutathione is not used as a substrate
by Erv1p (unpublished results). In that respect it is important
to notice that yeast Erv1p is the ¢rst sequenced sulfhydryl
oxidase with a documented essential role in the biogenesis
of mitochondria [1^3], especially in the maintenance of intact
mitochondrial membranes and a normal mitochondrial mor-
phology [7]. In the literature one ¢nds some evidence for a
connection between mitochondrial morphology and sulfhydryl
oxidase activity [22,23], but so far no other protein or gene
sequences have been determined. Most of these data are re-
lated to the investigation of sperm development in higher eu-
karyotes and the identi¢cation of proteins of 50^60 kDa with
sulfhydryl oxidase activities [23]. Whether those proteins have
any relation to Erv1p/Alrp or Q6 will remain unclear until
isolated proteins and their sequences are available.
An interesting new aspect for a mitochondrial sulfhydryl
oxidase activity and the formation of disul¢de bonds is the
recent ¢nding of a direct correlation between the electron
transport chain and the formation of disul¢de bonds [24,25]
in E. coli. But whether there also exists a functional correla-
tion between a mitochondrial sulfhydryl oxidase activity, the
mitochondrial electron transport chain and the formation of
disul¢de bonds in yeast remains highly speculative at the mo-
ment.
For higher eukaryotes it is important to notice that the
human Alrp domain with the CXXC motif can functionally
substitute the yeast domain in vivo [8,12] indicating that this
domain also has the enzymatic activity of a sulfhydryl oxi-
dase. Human Q6 protein and Alrp are both characterized as
growth factors and this is in agreement with the ¢nding that
redox proteins are important means to regulate and modulate
cell growth and the activity of enzymes or hormones [26,27].
For example many mammalian cytokines and growth factors
have recently been identi¢ed as thioredoxin proteins [26^28].
To understand the functional similarities and di¡erences of
Erv1p/Alrp and the Q6 proteins it will be important to iden-
tify their respective natural target proteins or molecules in the
living cell. Neither for Q6 nor for Erv1p are the in vivo targets
known yet. We assume that in accordance with the specialized
function of Erv1p and Alrp in mitochondrial biogenesis and
hepatic cell growth one will also ¢nd selective in vivo target
proteins or molecules like for many di¡erent proteins with
thioredoxin motifs [26,27].
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